Telemedicine for international travelers through a Smartphone-based monitoring platform (Trip Doctor®)

Rodriguez-Valero, Natalia; Ledesma-Carbayo, María J.; Camprubí-Ferrer, Daniel; Martí-Soler, Helena; Sánchez, Daniel Cuadrado; Vladimirov, Alexander; Pinazo, María Jesús; Almuedo-Riera, Alex; Román, Angely; Vera, Isabel; Roldán, Montserrat; Alba, T. de; Jiménez, Aurora; Gómez-Valverde, Juan J.; Luengo-Oroz, Miguel; Muñóz, José

doi:10.1016/j.tmaid.2022.102356

Cited by 4 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 81 Initiatives using smart phone telemedicine apps have shown usefulness, obviating the need for referral to a local doctor in 90% of travellers using the app, with symptomatic treatment as the main therapy prescribed. 82 When travellers develop symptoms after returning home, healthcare providers may not consider chikungunya as a potential diagnosis unless a travel history is obtained, since many symptoms are non-specific. 23 Nonetheless, symptoms such as chronic arthralgia are specific to chikungunya.…”

Section: Introductionmentioning

confidence: 99%

Chikungunya: risks for travellers

Simon

Caumes

Jelı́nek³

et al. 2023

Journal of Travel Medicine

View full text Add to dashboard Cite

Rationale for review: Chikungunya outbreaks continue to occur, with changing epidemiology. Awareness about chikungunya is low both among the at-risk travellers and healthcare professionals, which can result in underdiagnosis and underreporting. This review aims to improve awareness among healthcare professionals regarding the risks of chikungunya for travellers. Key findings: Chikungunya virus transmission to humans occurs mainly via daytime-active mosquitoes, Aedes aegypti and Aedes albopictus. The areas where these mosquitoes live is continuously expanding, partly due to climate changes. Chikungunya is characterized by an acute onset of fever with joint pain. These symptoms generally resolve within 1–3 weeks but at least one-third of the patients suffer from debilitating rheumatologic symptoms for months to years. Large outbreaks in changing regions of the world since the turn of the 21st century (e.g. Caribbean, La Réunion; currently Brazil, India) have resulted in growing numbers of travellers importing chikungunya, mainly to Europe and North America. Viremic travellers with chikungunya infection have seeded chikungunya clusters (France, United States of America) and outbreaks (Italy in 2007 and 2017) in non-endemic countries where Ae. albopictus mosquitoes are present. Community preventive measures are important to prevent disease transmission by mosquitoes. Individual preventive options are limited to personal protection measures against mosquito bites, particularly the daytime-active mosquitos that transmit the chikungunya virus. Candidate vaccines are on the horizon and regulatory authorities will need to assess environmental and host risk factors for persistent sequelae, such as obesity, age (over 40 years), and history of arthritis or inflammatory rheumatologic disease to determine which populations should be targeted for these chikungunya vaccines. Conclusions/recommendations: Travellers planning to visit destinations with active CHIKV circulation should be advised about the risk for chikungunya, prevention strategies, the disease manifestations, possible chronic rheumatologic sequelae, and if symptomatic, seek medical evaluation and report potential exposures.

show abstract

Section: Introductionmentioning

confidence: 99%

Chikungunya: risks for travellers

Simon

Caumes

Jelı́nek³

et al. 2023

Journal of Travel Medicine

View full text Add to dashboard Cite

show abstract

Updates on Malaria Epidemiology and Prevention Strategies

González-Sanz

Berzosa

Norman

2023

Curr Infect Dis Rep

View full text Add to dashboard Cite

Purpose of Review The objective of this review was to provide an update on recent malaria epidemiology, both globally and in non-endemic areas, to identify the current distribution and repercussions of genetically diverse Plasmodium species and summarize recently implemented intervention and prevention tools. Recent Findings Notable changes in malaria epidemiology have occurred in recent years, with an increase in the number of total cases and deaths globally during 2020–2021, in part attributed to the COVID-19 pandemic. The emergence of artemisinin-resistant species in new areas and the expanding distribution of parasites harbouring deletions of the pfhrp2/3 genes have been concerning. New strategies to curb the burden of this infection, such as vaccination, have been implemented in certain endemic areas and their performance is currently being evaluated. Summary Inadequate control of malaria in endemic regions may have an effect on imported malaria and measures to prevent re-establishment of transmission in malaria-free areas are essential. Enhanced surveillance and investigation of Plasmodium spp. genetic variations will contribute to the successful diagnosis and treatment of malaria in future. Novel strategies for an integrated One Health approach to malaria control should also be strengthened.

show abstract